Ask AI

Immune Checkpoint Blockade in NSCLC: Expert Perspectives on Current Standards and the Next Frontier

In this online educational program CCO&rsquo s expert faculty explore optimal care for patients with non-small-cell lung cancer focusing on the use of immune checkpoint inhibitors.

Share

Program Content

No activities added yet

Supporters

This activity is supported by an educational grant from

Merck Oncology